| 000 | 03251naaaa2200937uu 4500 | ||
|---|---|---|---|
| 001 | https://directory.doabooks.org/handle/20.500.12854/76707 | ||
| 005 | 20220220050106.0 | ||
| 020 | _abooks978-3-0365-1797-1 | ||
| 020 | _a9783036517988 | ||
| 020 | _a9783036517971 | ||
| 024 | 7 |
_a10.3390/books978-3-0365-1797-1 _cdoi |
|
| 041 | 0 | _aEnglish | |
| 042 | _adc | ||
| 072 | 7 |
_aM _2bicssc |
|
| 100 | 1 |
_aKorabecny, Jan _4edt |
|
| 700 | 1 |
_aSoukup, Ondrej _4edt |
|
| 700 | 1 |
_aKorabecny, Jan _4oth |
|
| 700 | 1 |
_aSoukup, Ondrej _4oth |
|
| 245 | 1 | 0 | _aCholinesterase Research |
| 260 |
_aBasel, Switzerland _bMDPI - Multidisciplinary Digital Publishing Institute _c2021 |
||
| 300 | _a1 electronic resource (223 p.) | ||
| 506 | 0 |
_aOpen Access _2star _fUnrestricted online access |
|
| 520 | _aThis collection of 10 papers includes original as well as review articles focused on the cholinesterase structural aspects, drug design and development of novel cholinesterase ligands, but also contains papers focused on the natural compounds and their effect on the cholinergic system and unexplored effects of donepezil. | ||
| 540 |
_aCreative Commons _fhttps://creativecommons.org/licenses/by/4.0/ _2cc _4https://creativecommons.org/licenses/by/4.0/ |
||
| 546 | _aEnglish | ||
| 650 | 7 |
_aMedicine _2bicssc |
|
| 653 | _aAmaryllidaceae | ||
| 653 | _aNarcissus pseudonarcissus cv. Carlton | ||
| 653 | _aalkaloids | ||
| 653 | _acarltonine A–C | ||
| 653 | _aAlzheimer’s disease | ||
| 653 | _abutyrylcholinesterase | ||
| 653 | _adocking studies | ||
| 653 | _aorganophosphorus nerve agents | ||
| 653 | _aoxime | ||
| 653 | _acholinesterase | ||
| 653 | _areactivation | ||
| 653 | _aventilation | ||
| 653 | _apharmacodynamics | ||
| 653 | _ablood-brain barrier crossing | ||
| 653 | _aacetylcholinesterase inhibitors | ||
| 653 | _abone healing | ||
| 653 | _aosseointegration | ||
| 653 | _adonepezil | ||
| 653 | _ahemostasis | ||
| 653 | _aacetylcholinesterase inhibitor | ||
| 653 | _adementia | ||
| 653 | _azebrafish | ||
| 653 | _abehavior | ||
| 653 | _aAlzheimer disease | ||
| 653 | _aantioxidants | ||
| 653 | _abutyrylcholinesterase inhibitors | ||
| 653 | _amolecular modelling | ||
| 653 | _anutraceuticals | ||
| 653 | _aphytochemicals | ||
| 653 | _aacetylcholinesterase | ||
| 653 | _aslow-binding inhibition | ||
| 653 | _atransition state analog | ||
| 653 | _aorganophosphorus | ||
| 653 | _aosmotic stress | ||
| 653 | _aneutron scattering | ||
| 653 | _amolecular dynamics | ||
| 653 | _aMD simulations | ||
| 653 | _afluorene | ||
| 653 | _ain vitro | ||
| 653 | _ain silico | ||
| 653 | _amulti-target directed ligands | ||
| 653 | _aN-methyl-d-aspartate receptor | ||
| 653 | _amolecular modeling | ||
| 653 | _areactivators | ||
| 653 | _areactivation process | ||
| 653 | _aorganophosphates | ||
| 653 | _adocking | ||
| 653 | _ahydrolysis | ||
| 653 | _amolecular recognition | ||
| 653 | _acatalysis | ||
| 653 | _ainhibition | ||
| 653 | _an/a | ||
| 856 | 4 | 0 |
_awww.oapen.org _uhttps://mdpi.com/books/pdfview/book/4156 _70 _zDOAB: download the publication |
| 856 | 4 | 0 |
_awww.oapen.org _uhttps://directory.doabooks.org/handle/20.500.12854/76707 _70 _zDOAB: description of the publication |
| 999 |
_c66632 _d66632 |
||